Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessing differences in epigenetic aging markers between sexual or gender minority and straight cisgender adults using the Coronary Artery Risk Development in Young Adults cohort.

Social science & medicine (1982)·2026
Same author

Real-world incidence of cancer therapy-related cardiac dysfunction in a large, diverse, and contemporary cohort.

ESC heart failure·2026
Same author

Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of Two Nationwide Randomized Trials.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Nudges for Guideline-Directed Medical Therapy in Chronic Kidney Disease: Long-Term Follow-Up of the NUDGE-CKD Trial.

Journal of the American College of Cardiology·2026
Same author

Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney disease.

ESC heart failure·2026
Same author

Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial.

European heart journal open·2026

相关实验视频

Updated: Jun 8, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.6K

心血管临床试验中的人工智能

Jonathan W Cunningham1, William T Abraham2, Ankeet S Bhatt3

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Journal of the American College of Cardiology
|November 6, 2024
PubMed
概括
此摘要是机器生成的。

人工智能 (AI) 可以通过自动化流程和提高效率来增强心血管临床试验. 然而,仔细整合至关重要,以减轻诸如偏见和隐私问题等风险,确保试验有效性.

关键词:
人工智能的人工智能是人工智能.这是自动化的自动化.大型语言模型随机的,随机的,随机的,随机的,随机的

更多相关视频

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

12.7K

相关实验视频

Last Updated: Jun 8, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

12.7K

科学领域:

  • 心血管医学 心血管医学
  • 临床试验方法论 临床试验方法论
  • 医疗保健中的人工智能

背景情况:

  • 随机临床试验对于心血管治疗评估至关重要,但面临成本,持续时间和多样性的挑战.
  • 人工智能 (AI) 提供了优化临床试验过程的机会.

研究的目的:

  • 审查AI在整个心血管临床试验生命周期中的潜在应用.
  • 确定与将人工智能纳入临床试验相关的风险和挑战.
  • 讨论在医学研究中评估人工智能工具的不断发展的框架.

主要方法:

  • 在临床试验设计,患者鉴定,数据收集,结果确定,成像解释和结果传播中对人工智能应用的文献综述.
  • 对潜在风险的分析,包括数据准确性,算法偏见和患者隐私.
  • 检查当前对AI在研究中的监管和期刊准则.

主要成果:

  • 人工智能可以简化各种试验阶段,从设计到数据分析和传播.
  • 显著的风险包括不准确的AI输出,偏见的放大和隐私侵犯.
  • 监管机构和期刊正在制定框架,以解决临床研究中的AI问题.

结论:

  • 人工智能为心血管临床试验提供了变革性的潜力,提高了效率和潜在的多样性.
  • 需要仔细,透明地实施,以管理与人工智能相关的风险并保持试验完整性.
  • 评估框架的持续开发对于在临床研究中负责任地采用人工智能至关重要.